These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8829118)

  • 21. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.
    Okuhara Y; Hirotani S; Naito Y; Nakabo A; Iwasaku T; Eguchi A; Morisawa D; Ando T; Sawada H; Manabe E; Masuyama T
    J Card Fail; 2014 May; 20(5):295-301. PubMed ID: 24462960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites.
    Misra VL; Vuppalanchi R; Jones D; Hamman M; Kwo PY; Kahi C; Chalasani N
    Aliment Pharmacol Ther; 2010 Oct; 32(8):1044-50. PubMed ID: 20937051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose atrial natriuretic factor and furosemide in experimental acute congestive heart failure.
    Fett DL; Cavero PG; Burnett JC
    J Am Soc Nephrol; 1993 Aug; 4(2):162-7. PubMed ID: 8400079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of the renal kallikrein-kinin system in furosemide-induced natriuresis in rats.
    Fujita T; Kumagai Y; Ikeda Y; Inamura N; Iwata T; Ogino M; Majima M
    Jpn J Pharmacol; 2000 Oct; 84(2):133-9. PubMed ID: 11128035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial.
    Sharma K; Vaishnav J; Kalathiya R; Hu JR; Miller J; Shah N; Hill T; Sharp M; Tsao A; Alexander KM; Gupta R; Montemayor K; Kovell L; Chasler JE; Lee YJ; Fine DM; Kass DA; Weiss RG; Thiemann DR; Ndumele CE; Schulman SP; Russell SD;
    JACC Heart Fail; 2018 Oct; 6(10):859-870. PubMed ID: 30098962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans.
    Swärd K; Valsson F; Sellgren J; Ricksten SE
    Intensive Care Med; 2005 Jan; 31(1):79-85. PubMed ID: 15565364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.
    Paterna S; Di Gaudio F; La Rocca V; Balistreri F; Greco M; Torres D; Lupo U; Rizzo G; di Pasquale P; Indelicato S; Cuttitta F; Butler J; Parrinello G
    Adv Ther; 2015 Oct; 32(10):971-82. PubMed ID: 26521190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
    Costello-Boerrigter LC; Smith WB; Boerrigter G; Ouyang J; Zimmer CA; Orlandi C; Burnett JC
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F273-8. PubMed ID: 16189291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure.
    Knauf H; Mutschler E
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):394-400. PubMed ID: 8583780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance.
    van Meyel JJ; Smits P; Dormans T; Gerlag PG; Russel FG; Gribnau FW
    J Intern Med; 1994 Apr; 235(4):329-34. PubMed ID: 8151264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addition of indapamide to frusemide increases natriuresis and creatinine clearance, but not diuresis, in fluid overloaded ICU patients.
    Bihari S; Holt AW; Prakash S; Bersten AD
    J Crit Care; 2016 Jun; 33():200-6. PubMed ID: 26948252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
    Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
    Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure.
    Ungar A; Fumagalli S; Marini M; Di Serio C; Tarantini F; Boncinelli L; Baldereschi G; Valoti P; La Cava G; Olianti C; Masotti G; Marchionni N
    Crit Care Med; 2004 May; 32(5):1125-9. PubMed ID: 15190961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure.
    Pivac N; Rumboldt Z; Sardelić S; Bagatin J; Polić S; Ljutić D; Naranca M; Capkun V
    Int J Clin Pharmacol Res; 1998; 18(3):121-8. PubMed ID: 9825268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
    Ng TM; Hshieh S; Chan CY; Elkayam U
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic and natriuretic effects of bumetanide and furosemide in the cat.
    Friedman PA; Roch-Ramel F
    J Pharmacol Exp Ther; 1977 Oct; 203(1):82-91. PubMed ID: 909060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure.
    Starklint J; Bech JN; Nyvad O; Jensen P; Pedersen EB
    Scand J Clin Lab Invest; 2006; 66(1):55-66. PubMed ID: 16464787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.